Stroffekova K, Proenza C, Beam K G
Department of Anatomy and Neurobiology, Colorado State University, Fort Collins 80523, USA.
Pflugers Arch. 2001 Sep;442(6):859-66. doi: 10.1007/s004240100619.
FLASH-EDT2--4',5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein-(1,2-ethanedithiol)2--has been reported to fluoresce only after binding with high affinity to a specific tetracysteine motif (CCXXCC, "Cys4") and thus to provide a technique for labeling recombinant proteins in vivo (Griffin et al. Science 281:269-272). We have attempted to use FLASH-EDT2 as a site-specific label of the II-III loop of the dihydropyridine receptor (DHPR) in skeletal muscle. Upon expression in dysgenic myotubes (which lack endogenous alpha1s), an alpha1s mutated to contain CCRECC in the II-III loop was able to produce L-type calcium currents and to mediate skeletal-type excitation-contraction (EC) coupling, but FLASH-EDT2 labeling revealed no difference from non-transfected dysgenic myotubes. HeLa-S3 cells transfected with Cys4-containing calmodulin were significantly more fluorescent than non-transfected cells, whereas the difference between transfected and non-transfected cells was less apparent for CHO-K and HEK 293 cells. Because the fluorescence of non-transfected cells increased substantially after treatment with FLASH-EDT2, it suggested the possibility that FLASH binds to endogenous cysteine-containing proteins. This finding was confirmed in cuvette experiments in which FLASH-EDT2 fluorescence was observed after FLASH-EDT, was added to protein homogenates from myotubes or cell lines. The enhanced fluorescence was abolished by pretreatment of cells or cell homogenates with coumarine maleimide (CPM), which modifies cysteine residues covalently. Thus, enhanced FLASH fluorescence appears to occur both after binding to an introduced Cys4 motif and to endogenous, cysteine-containing proteins. Therefore, FLASH-EDT2 may be useful only for labeling those recombinant proteins that express at a very high level.
据报道,FLASH-EDT2(4',5'-双(1,3,2-二硫代砷杂环戊烷-2-基)荧光素-(1,2-乙二硫醇)2)只有在与特定的四半胱氨酸基序(CCXXCC,“Cys4”)高亲和力结合后才会发出荧光,从而提供了一种在体内标记重组蛋白的技术(格里芬等人,《科学》281:269-272)。我们试图将FLASH-EDT2用作骨骼肌中二氢吡啶受体(DHPR)II-III环的位点特异性标记。在发育不良肌管(缺乏内源性α1s)中表达时,在II-III环中突变以包含CCRECC的α1s能够产生L型钙电流并介导骨骼肌型兴奋-收缩(EC)偶联,但FLASH-EDT2标记显示与未转染的发育不良肌管没有差异。用含Cys4的钙调蛋白转染的HeLa-S3细胞比未转染的细胞荧光明显更强,而对于CHO-K和HEK 293细胞,转染和未转染细胞之间的差异不太明显。由于未转染细胞在用FLASH-EDT2处理后荧光大幅增加,这表明FLASH可能与内源性含半胱氨酸的蛋白结合。这一发现在比色皿实验中得到证实,在该实验中,将FLASH-EDT2添加到肌管或细胞系的蛋白质匀浆中后观察到了FLASH-EDT2荧光。用香豆素马来酰亚胺(CPM)对细胞或细胞匀浆进行预处理可消除增强的荧光,CPM可共价修饰半胱氨酸残基。因此,增强的FLASH荧光似乎在与引入的Cys4基序结合以及与内源性含半胱氨酸的蛋白结合后都会出现。因此,FLASH-EDT2可能仅对那些高水平表达的重组蛋白标记有用。